Trial Profile
The effect of Exenatide on satiety, metabolic parameters and regional brain activation in response to nutrient ingestion in Type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2011
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 17 Oct 2011 New trial record